Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Work
Year: 2008
Type: article
Source: The Lancet Oncology
Institutions National Taiwan University Hospital, Asan Medical Center, First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Chi Mei Medical Center +21 more
Cites: 40
Cited by: 5,544
Related to: 10
FWCI: 95.66
Citation percentile (by year/subfield): 99.98
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed